At the moment, the 30-year mortgage rates sit just above 7.09%. That’s the highest it’s been since April 2022. And unfortunately, with rates above 7%, a good deal of people aren’t buying or selling homes. Fears of 8% -- which…
Keep an eye on 13F filings. Filed quarterly by all institutional investment managers with at least $100 million in assets, these are a great way to see where the big money has been flowing. Unfortunately, it’s also a look into…
Always be prepared. If investors become too bullish for an extended period of time, be prepared for downside. If they’re too bearish, be prepared for upside. It’s how some of the most successful investors became wealthy. Sir John Templeton taught…
Oil prices are gushing higher. Last checked, oil was up another 87 cents to $81.45, and could push higher. The last time we spoke about potential opportunities in oil, it traded at around $72 a barrel. In fact, we also…
Over the next few weeks, millions of students will head back off to school. This year, consumers are expected to spend up to $41.5 billion for back to school gear, which should pass the $37.1 billion spent in 2021. Back…
Keep an eye on Mattel (MAT). While the stock has priced in a good deal of success from blowout $155 million Barbie film sales, it could race even higher over the long-term. For one, according to The New Yorker, the…
It is disgustingly hot outside. For some, that doesn’t matter. In fact, some folks decided to take a trip to Death Valley – the hottest place on earth – to experience how triple digit temperatures feel against their skin. Temperatures…
Keep an eye on the Teucrium Wheat ETF (WEAT), and other wheat-related stocks, such as MGP Ingredients (MGPI), Bunge (BG), and Adecoagroo (AGRO). With an expense ratio of 0.28%, the ETF provides investors a way to gain access to wheat…
Coinbase (COIN) is on the move. Last checked, the stock was up about 15% on a volume spike to 33.88 million shares, as compared to daily average volume of 15.28 million. All after Ripple won a partial win in a…
The AI boom is still alive and well. Now, Recursion Pharmaceuticals is joining in thanks to a $50 million investment from Nvidia. At the moment, the drug maker is using machine learning to discover new medicines. This cements Recursion’s leading…